Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Κατάταξη σε μετοχές
#4334
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Τιμή μετοχής
$3.87
Κεφαλαιοποίηση
$3.57B
Αλλαγή (1 ημέρα)
-1.64%
Αλλαγή (1 έτος)
9.08%
Χώρα
CN
Εμπόριο Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Κατηγορία
Healthcare
Δείκτης P/B για Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Δείκτης P/B στις October 2026 TTM: 1.74
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Hubei Jumpcan Pharmaceutical Co., Ltd., ο τρέχων δείκτης P/B (TTM) είναι 1.74. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 1.81.
Ιστορικό P/B για την Hubei Jumpcan Pharmaceutical Co., Ltd. από 2001 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 1.74 | 4.72% |
| 2025 | 1.66 | -8.58% |
| 2024 | 1.81 | -20.64% |
| 2023 | 2.29 | 7.03% |
| 2022 | 2.14 | -22.64% |
| 2021 | 2.76 | 26.93% |
| 2020 | 2.18 | -32.61% |
| 2019 | 3.23 | -28.06% |
| 2018 | 4.49 | -36.34% |
| 2017 | 7.05 | 3.38% |
| 2016 | 6.82 | -15.47% |
| 2015 | 8.07 | 21.15% |
| 2014 | 6.66 | -37.14% |
| 2013 | 10.59 | 28.54% |
| 2012 | 8.24 | 390.60% |
| 2011 | 1.68 | -34.12% |
| 2010 | 2.55 | 54.33% |
| 2009 | 1.65 | 76.47% |
| 2008 | 0.94 | -55.17% |
| 2007 | 2.09 | 104.82% |
| 2006 | 1.02 | 4.08% |
| 2005 | 0.98 | -17.76% |
| 2004 | 1.19 | -24.51% |
| 2003 | 1.58 | -39.47% |
| 2002 | 2.61 | -31.82% |
| 2001 | 3.82 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | -24.51% |
JP
|
|
| 6.3468 | 265.09% |
CH
|
|
| 5.041 | 189.98% |
IN
|
